ID   H5D.7
AC   CVCL_X360
SY   H5D-7
DR   Wikidata; Q54872194
RX   CelloPub=CLPUB00147;
RX   PubMed=2193646;
RX   PubMed=9745712;
CC   Transformant: ChEBI; CHEBI_76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6734 ! H5D
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
RX   CelloPub=CLPUB00147;
RA   Faris R.A., Monfils B.A., Brown J., Yang L., Affigne S., Marceau N.,
RA   Hixson D.C.;
RT   "H5D.7, an azo dye induced transplantable hepatocellular carcinoma cell
RT   line that possesses multipotential stem cell properties.";
RL   Proc. Am. Assoc. Cancer Res. 31:156.931-156.931(1990).
//
RX   PubMed=2193646; DOI=10.1159/000163565;
RA   Hixson D.C., Faris R.A., Thompson N.L.;
RT   "An antigenic portrait of the liver during carcinogenesis.";
RL   Pathobiology 58:65-77(1990).
//
RX   PubMed=9745712; DOI=10.1111/j.1432-0436.1998.00215.x;
RA   Zvibel I., Fiorino A.S., Brill S., Reid L.M.;
RT   "Phenotypic characterization of rat hepatoma cell lines and
RT   lineage-specific regulation of gene expression by differentiation
RT   agents.";
RL   Differentiation 63:215-223(1998).
//